Serum klotho and FGF23 Levels in Patients with Schizophrenia

KAZĞAN KILIÇASLAN A., YILDIZ S., Emir B. S., KILIÇ F., Atmaca M.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.32, sa.3, ss.229-236, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5152/pcp.2022.22406
  • Dergi Adı: PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.229-236
  • Anahtar Kelimeler: Fibroblast growth factor 23, inflammation, klotho, schizophrenia, serum, CEREBROSPINAL-FLUID, VITAMIN-D, COGNITION, DEPRESSION, RELEASE, MODEL
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Background: The aim of this study is to compare the serum levels of Klotho and fibroblast growth factor 23 in patients with schizophrenia, in whom etiopathogenesis inflammation plays an important role, with those of healthy control subjects and to investigate a possible correlation between these levels.